Vasculogenesis Factor – Definition and Significance
Vasculogenesis factors are signaling molecules that control the formation of new blood vessels from precursor cells. They play a key role in embryonic development and tissue regeneration.
Wissenswertes über "Vasculogenesis Factor"
Vasculogenesis factors are signaling molecules that control the formation of new blood vessels from precursor cells. They play a key role in embryonic development and tissue regeneration.
What Is a Vasculogenesis Factor?
A vasculogenesis factor is a biological signaling molecule – typically a protein or growth factor – that regulates the process of vasculogenesis. Vasculogenesis refers to the de novo formation of blood vessels from undifferentiated precursor cells known as angioblasts or endothelial progenitor cells (EPCs). This process is fundamentally different from angiogenesis, in which new vessels sprout from pre-existing blood vessels.
Vasculogenesis factors are particularly active during embryonic development, where they coordinate the establishment of the primary vascular network. In modern medicine, they are also of great importance in the context of wound healing, tumor biology, and regenerative medicine.
Key Vasculogenesis Factors
Several molecules are considered central vasculogenesis factors. The most important include:
- VEGF (Vascular Endothelial Growth Factor): The most well-known vasculogenesis and angiogenesis factor. It binds to specific receptors on endothelial cells and promotes their proliferation, migration, and survival.
- FGF (Fibroblast Growth Factor): Promotes the differentiation of mesodermal cells into angioblasts and supports early vessel formation.
- PDGF (Platelet-Derived Growth Factor): Involved in the maturation and stabilization of newly formed vessels by recruiting pericytes and smooth muscle cells.
- Angiopoietin-1 and Angiopoietin-2: Regulate vessel maturation and stability through the Tie-2 receptor.
- SCF (Stem Cell Factor) and SDF-1 (Stromal Cell-Derived Factor 1): Mobilize endothelial progenitor cells from the bone marrow and direct them to sites where new vessels are needed.
Mechanism of Action
Vasculogenesis factors typically act through specific receptor tyrosine kinases on the surface of target cells. Upon binding of the factor to its receptor, intracellular signaling cascades are activated that trigger the following processes:
- Proliferation of endothelial progenitor cells
- Migration of cells to the site of new vessel formation
- Differentiation into mature endothelial cells
- Formation of tubular structures (lumen formation)
- Stabilization of the newly formed vessel
Role in Embryonic Development
During early embryonic development, angioblasts first form a primitive capillary network known as the primary vascular plexus. Vasculogenesis factors coordinate the spatial and temporal differentiation of this network. Mutations or loss-of-function events in genes encoding these factors frequently lead to severe developmental defects or are incompatible with life.
Clinical Relevance
Tumor Biology
Tumors depend on an adequate blood supply and therefore produce large amounts of vasculogenesis factors – particularly VEGF. This enables tumor growth and metastasis. On this basis, anti-angiogenic therapies have been developed that specifically inhibit vasculogenesis and angiogenesis factors to halt tumor growth.
Regenerative Medicine
In regenerative medicine and tissue engineering, vasculogenesis factors are used to promote the vascularization of artificial tissue constructs or to enhance the healing of poorly perfused wounds. Targeted delivery of growth factors is an active area of research, particularly for chronic wounds, diabetic ulcers, and ischemic conditions.
Cardiovascular Disease
In conditions such as myocardial infarction or peripheral arterial occlusive disease, therapeutic angiogenesis and vasculogenesis are being investigated as treatment strategies to stimulate new blood vessel growth in underperfused tissue.
Diagnostic and Therapeutic Significance
The detection of specific vasculogenesis factors in blood or tissue can serve as a biomarker for various diseases. Elevated VEGF levels, for example, are observed in certain cancers, rheumatoid arthritis, and diabetic retinopathy. Therapeutically, inhibitors of these factors – such as bevacizumab (an anti-VEGF antibody) – are used in oncology and ophthalmology.
References
- Risau W. - Mechanisms of angiogenesis. Nature. 1997;386(6626):671-674.
- Carmeliet P. - Angiogenesis in life, disease and medicine. Nature. 2005;438(7070):932-936.
- Ferrara N., Gerber H.P., LeCouter J. - The biology of VEGF and its receptors. Nature Medicine. 2003;9(6):669-676.
Best-selling products
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryExtrauterine
Pelvic Venous Pressure
Lactate Dehydrogenase Elevation
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Vasculogenesis Factor + Vasculogenesis Factors + Vasculogenetic Factor